The Latest Cardiac and Vascular News
MARLBOROUGH, Mass., September 14, 2021 – CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has entered into an agreement with IsoLase Ltd. to acquire IsoLase’s patent portfolio. The acquisition agreement includes US patents 8,992,514 and 10,517,669 and EU patent […]
Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Financial Execution with High Growth Companies SAN FRANCISCO, Sept. 13, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Quentin Blackford has […]
Acquiring provider of home sleep apnea diagnosis solutions will allow ZOLL to better serve undiagnosed and untreated cardiac patients CHELMSFORD, Mass. & CAESAREA, Israel–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and […]
EINDHOVEN, Netherlands, Sept. 13, 2021 /PRNewswire/ — STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for treatment of cardiovascular diseases, today announced the appointment of its Medical Advisory Board, chaired by Prof. Patrick Serruys and complemented by Prof. Marc van Sambeek and Prof. Yoshinobu Onuma. Bart Sanders, CEO of STENTiT, said: “We are excited to receive […]
Xenter Medical Technologies Expands, Focuses Initially on the Development of a New Wireless Vascular Imaging and Physiology Platform, Prepares New Global Platform to Collect and Store Physical Intelligence SALT LAKE CITY–(BUSINESS WIRE)–Following the formation of the Xenter Therapeutics business unit, Xenter, Inc. (XenterMD.com), the first purpose-built medical device-data-drug technologies company, today announced […]
Proceeds from new investors will fund in vivo and clinical development of innovative platform for aneurysmal disease, including Abdominal Aortic Aneurysms (AAA) TEMPE, Ariz.–(BUSINESS WIRE)–Nectero Medical Inc. today announced the closing of its $19.5 million Series C financing round, led by new investor Boston Scientific Corporation, a leading global medical device manufacturer. Proceeds […]
DALLAS, Sept. 9, 2021 /PRNewswire/ — Venturis Therapeutics, Inc. (“VT” or the “Company”) announced it has entered into a strategic alliance with Prevail InfoWorks, Inc. (“InfoWorks”), with the intent to deploy InfoWorks’ cutting-edge capabilities and technology to take a leadership position in the management and the advancement of the VT Coronary Artery […]
New partnership will enable clinical decision-support solutions to improve perioperative care BOSTON & ANN ARBOR, Mich.–(BUSINESS WIRE)–Etiometry, a leader in clinical decision-support software for critical care, today jointly announced a new collaboration with Terumo Cardiovascular, a global leader in cardiovascular surgery technologies and a subsidiary of Japan-based Terumo Corporation (TSE: 4543). The partnership […]
– TN-201 MYBPC3 gene therapy product candidate for the leading genetic cause of hypertrophic cardiomyopathy granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) – Expanded leadership team appointing Leone Patterson as Chief Financial and Business Officer and Matt Pollman, MD, as SVP, Clinical Development – Completed Initial Public […]
BAAR, Switzerland and MOUNTAIN VIEW, Calif., Sept. 8, 2021 /PRNewswire/ — atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced the appointment of Andrew Cleeland to the company’s Board of Directors. With over thirty years of experience, including specific expertise bringing game-changing technologies to […]
